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Bordetellapertussis,the causativeagentof whoopingcough,has
clinical
manywell-studiedvirulencefactorsand a characteristic
presentation.Despite this information,
it is not clear how B.
withhostcellsleads to disease. Inthisstudy,
pertussisinteraction
ofB.pertussiswitha humanbronchial
we examinedtheinteraction
epithelialcell line (BEAS-2B)and measuredhost transcriptional
DNA microarrays.
profilesby using high-density
The earlytranscriptionalresponseto this pathogen is dominatedby altered
expressionof cytokines,DNA-binding
proteins,and NFKB-regulatedgenes.Thispreviously
unrecognizedresponseto B. pertussis
was modifiedin similarbut nonidenticalfashionsby the antiinflammatory
agents dexamethasoneand sodiumsalicylate.Cytokine proteinexpressionwas confirmed,
as was neutrophilchemoattraction.We show that B. pertussisinduces mucingene
transcription
byBEAS-2Bcellsthencountersthisdefensebyusing
mucinas a bindingsubstrate.A set of genes is describedforwhich
the catalyticactivityof pertussistoxin is both necessaryand
to regulatetranscription.
sufficient
Host genomictranscriptional
profiling,
in combinationwithfunctionalassays to evaluate subsequent biologicalevents,providesinsightinto the complexinteractionof hostand pathogen.

B

ordetella
pertussisis a Gram-negativecoccobacillus and the
causative agent of whooping cough in humans. It is a
well-studied
pathogenwitha numberofpotentvirulencefactors.
However,littleis known about the responses elicited by this
organism in human cells, especially at the level of gene
transcription.
victimsperformed
in theearly20th
Autopsystudiesofpertussis
withincreasedsecenturyrevealeda diffusebronchopneumonia
cretionof mucus,associatedwithairwaypluggingand atelectasis
(1). Bacteriawereseentightly
packedbetweentheciliaofepithelial
cells, which desquamated duringinfection.Rodent models of
ofmonocytes,
Bordetella
infection
haverevealedinfiltrates
pertussis
and lymphocytes
neutrophils,
in thelung(2).
B. pertussisexpressesseveralvirulencefactorsdirectedat the
hostepithelium.Filamentoushemagglutinin
is themajoradhesin
ofB. pertussisforbronchialepithelialcells (3). B. pertussisalso
produces several toxins,includingpertussistoxin (PT). PT is
associatedwitha panoplyofbiologicaleffects,
manyofwhichare
linkedto its ADP-ribosyltransferase
activity.ADP ribosylation
of the Ga familyofhostproteinspreventstheirusual regulatory
responseto G-protein-linked
receptorengagement(4). B. pertussisalso secretesan adenylatecyclase toxinthat entershost
cells and raisesintracellularcAMP concentrations(5). Tracheal
cytotoxin(TCT), a muramyltetrapeptidebacterial cell wall
fragment,in combinationwith lipopolysaccharide,paralyzes
respiratoryepithelialcilia and ultimatelycauses cell death and
extrusionthroughpathwaysinvolvingIL-1 and nitric oxide
synthase(iNOS) (6). The molecularmechanismsthroughwhich
B. pertussisexertsthese effectsand bywhichhost cells attempt
to counterthispathogenicstrategyremainlargelyundescribed.

The goal ofthisstudywas to understandthepathologycaused
by B. pertussisand to explore whetherearly transcriptional
responses reveal pathogenic mechanismsand pathologyat a
molecularlevel.Our approachinvolvedgenome-wideexpression
analysisof a humanbronchialepithelialcell line exposed to B.
pertussis,coupled withfunctionalanalyses.
Materialsand Methods
BacterialStrains,
Toxins,
andCellLines.Wild-type
B. pertussis
BP536
(3) and an isogenicderivative
expressing
a catalytically
inactivePT,
BP-9K/129G (7), were grownat 37?C on Bordet-Gengouagar
(Difco),supplemented
withsheepblood (13% v/v)and 100 ,tg/ml
streptomycin.
Bordetellae were suspended in Eagle's minimal
essentialmedium(EMEM) withoutFCS overnight
at 37?C in 5%
CO2. Theywerethenadded to 2 x 107 epithelialcellsat a ratioof
50 bacteriapercell.Purifiedwild-type
and catalytically
inactivePT
(7) were added to 2 x 107 epithelialcells at a concentration
of 1
humanbronchialepithelialcell-line
Ag/ml.The SV40-transformed
BEAS-2B (8) was grownin EMEM with10% FCS at 37?C in 5%
CO2. A humancolon carcinomacell line,HM3, was stablytransoftheMUC2 orMUC5AC promoterfused
fectedwitha construct
to a luciferasereportergene.Transfected
cellsweremaintainedin
DMEM withhighglucoseand 10% FCS.
Scheme.BEAS-2B cells (1-1.5 x 107) wereincubatedfor
Infection
8 h, then some were treated for 1 hr with 10 mM sodium
salicylateor 1 ,tM dexamethasone.The cells were theninfected
withB. pertussis,exposedto PT, or mockinfected,and incubated
at 37?C for 3 h. Cells were washed with Hanks' balanced salt
solution(HBSS), released fromthe flaskwith5 mM EDTA in
HBSS, pelleted at 200 x g for5 min and frozenat -80?C.
Microarray
Expression
Analysis.
Total RNA was extractedfromcell
pelletsby usingTrizol (Life Technologies,Rockville,MD) and
resin(RNeasy, Qiagen, Chatsworth,
purifiedbyusingan affinity
CA). Microarrayanalysiswas performedaccordingto the Affymetrix
ExpressionAnalysisTechnicalManual withthefollowfirst-strand
ing exceptions (see http://relman.stanford.edu):
cDNA synthesis
was performedat 42?C,and 10 ptgoftotalRNA
Thispaperwas submitted
directly
(TrackII)to the PNASoffice.
oxidesynthase;
Abbreviations:
PT,pertussis
toxin;TCT,trachealcytotoxin;
iNOS,nitric
GRO,
growth-regulated
oncogene.
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on page 13467.
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Table 1. Epithelial cell transcriptionalprofile after exposure to B. pertussis
Down-regulatedtranscripts
Accessionno.

Ratio

GDB/othernames

Up-regulatedtranscripts
Ratio
Chemokines/Cytokines
+22.38
+16.29
+9.11
+6.80
+6.47

-3.03

X51435
D88613
U10324
N/A
X59244
X55544
M29581
M96843
U78722
U28687
N/A
U19557
U90546
X64877
S75256
M21642
X97064
X71661
L41390
U14550

-3.44

AC002115
M61853
M60891
D49488
U75362
S72370
X59834
M84424
M64082
D28791
D10040

-4.76
-3.85

M32315
N/A
L36531
M23197
U64871
U04811
Y09392
X16983
U61500
X77753
S67798
D31784
S83249
U80811
L07261

13848

I
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Accessionno.

X54489
M28130
Y00787
X04500
N/A
M57731
X04602
M23178
X53800
Transcription
factors/Zn-finger
proteins
ZNF40/HIVEP1
+7.39
M59465
HGCM/GCMA
X65663
ILF3/NF90
M82882
MYBL1/A-MYB
U69127
U18259
ZNF43/zinc-finger
protein
ATF1/TREB36
ZNF8/zinc-finger
protein8
DNA binding
ID2/inhibitor
ZNF165/zinc-finger
protein
ZNF157/zinc-finger
protein
BTF3homologue
Secretedmolecules
+4.59
M57730
SCCA2/proteaseInhibitor
BTN3A2/butyrophilin
M31166
HFL3/Hfactorcomplement
X57579
2
X75308
LCN2/lipocalin
III
AT3/antithrombin
M31551
ER/Golgiassociated
SEC23A
L10333
LMAN-1
U27326
/ERGIC-53/lectin
acetylglucosaminyltransfer
STHM/sialyltransferase
Metabolic/synthetic
D38524
COX6B/cytochrome
c oxid.
X78711
CYP2C17/P45011C17
M61855
UROD/decarboxylase
a transfer
Z94753
TTPA/tocopherol
USP13/ubiquitinprotease
PC/pyruvate
carboxylase
GLUL/glutamine
synthase
E
CTSE/cathepsin
FMO1/monooxygenase1
PIGA/phosphateinositolglycan
FACL1/fatty-acid-coA
ligand
Cell surfacemolecules/Receptors
TNFRSF1
+4.53
Y00285
B/TNFreceptor2
PSG11/glycoprotein
+4.30
M24283
+3.27
U92971
ITGA8/integrin
alpha 8
CD33
S59184
K02405
GPR19/Gprotein-coupled
U11878
TRO/Trophinin
U65011
TNFRSF12/APO-3/TNFR
ITGA4/CD49D/integrin
TMEM1/EHOC-1
M1S1/TROP-2/GA733-1
SPAM1/spermadhesion
CDH6/cadherin-6
NG-TRA/hormone
pump
EDG2/G-protein-coupled
Cytoskeleton
ADD 1/a adducin 1
L20826
U34301

GDB/othernames
GRO1/SCYB1/MGSA
IL8
IL8
IL1B
MCP1/SCYA2
GRO2/SCYB2/MIP-2a
IL6/IFNB2
SCYA3/MIP-1a
GRO3/SCYB3/MIP-2a
TNFAIP3/A20
SOX6
ELF1/E74-like
factor
FUBP3/(FUSE)-binding
protein3
MHC2TA/CIITA-8

Al
EFNA1/LERK1/B61/Ephrin
PTX3/pentaxin-related/TSG-14
f A/activin
INHBA/inhibin,
MMP13/collagenase3
active inhibitor
PAI2/plasminogen
1
RTN1/reticulon
3
FUT3/fucosyltransferase

Cytosolicpurine5'-nucleotidase
kinasedeficiency
GK/glycerol
CYP2C9/cytochrome
P450, Ilc
ATP7A/Cu++ ATPase

II receptor
IGF2R/IGF
ICAM1/CD54
F2RL2/thrombin
receptor-like
RYK/receptor
tyrosinekinase
f
HLA-DQB1/HLA-DC-3
CXCR2/IL8RB/IL-8
receptor
of melanoma
PRAME/antigen

PLS1/l-plastin
Nonmusclemyosinheavychain

Beicher
eta!.

Table 1. Continued
Down-regulatedtranscripts
Ratio

Accessionno.
U48736
M38258
U18671
M35416
U40371
U77845
X78549
U20158
U17327
U01833
U47414
D26528

GDB/othernames

Up-regulatedtranscripts
Ratio

Intracellularsignaling
PRP4h/ser-thr
proteinkinase
+3.47
RARG/retinoic
acid receptor
+3.27
STAT2
RALB/v-ral
homolog B
PDE1C/phosphodiesterase
hTRIP/TRAF-interacting
PTK6/BRK
LCP2/SLP-76
NOS1/nitric
oxide synthase
DNA replication/transcription
NUBP1/nucleotide
binding
+3.31
CCNG2/cyclin
G2
DDX7/RNAhelicase

Accessionno.

GDB/othernames

L42373
M69043
U77129
M80563
U37546

PPP2R5A/protein
phosphatase
NFKBIA/IKBA/MAD-3
MAP4K5/KHS1/kinase
S100A4/CAPLcalciumbinding
API2/1APhomolog C/MIHC

N/A
X54993
X95152

POLE/DNApolymerase,e
box binding
TBP/TFIID/TATA
cancer2
BRCA2/breast

The experiment
ratiosabove or below the uninfected
was repeatedtwiceindependently;
data fromone experiment
are shown.Absolutedifference
transcription
are notreportedwhenone ofthetwo valueswas lessthan2-foldthe background
noiselevel.

was used. Triton X-100 (0.01%) was used in hybridization
solutionsand buffersinstead of Tween 20. Labeled cRNA (20
,tg) was hybridizedto Affymetrix
HU6800 GENECHIP microarrays (Affymetrix,
Santa Clara, CA) for 18 h in bufferwithout
EDTA. The arrayswere rinsedwith 6x standardsaline phosphate/EDTA (SSPET, 0.18 M NaCI/10 mM phosphate, pH
7.4/1 mM EDTA), washed in 0.1X Mes at 50?C for30 min on
a rotisserieat 60 rpm,and then rinsedin 1x Mes. Hybridized
RNA was fluorescently
labeled by incubationin streptavidinR-phycoerythrin
conjugate (Molecular Probes) stainingbuffer
at 40?C for 15 min, then washed with 6X SSPET at 22?C.
Quantitativeanalysisof hybridization
patternsand intensities
were performed as previously described (9) (see http://
relman.stanford.edu).

Promega) and then frozenat -80?C. The luciferaseassay was
recommendations.
carriedout per manufacturer
For binding,2.5 ,tg of bovine submaxillarymucin type I-S
plate at 37?C. Mucin(Sigma) was desiccatedonto a microtiter
treatedand -untreatedplates were thenwashed with PBS and
blockedwith5% driednonfatmilkinPBS for1 h at 37?Cand again
washed with PBS. A suspensionof B. pertussislabeled with a
solutionofFITC for20 minwas thenaddedto theplates
250-Ag/ml
2.5 x 108oflabeledbacteriawereaddedper
for1 h.Approximately
well.Nonadherentbacteriawerewashedawaywiththreecyclesof
PBS washings.Plateswere thenread in a 96-wellfluorimeter.

Results
withB.pertussis
Profile
ofBEAS-2B
CellsInfected
TheTranscriptional
inPertussis.
AlthoughthepatholRevealstheBasisofInflammation
andApoptosisQuantitation.
Cytokine
For cytokineanalysis,96-well ogyofpertussishas been studiedfordecades,littleis knownabout
We examinedthe
plateswere coated with0.2 jig of capturemAb (MAB 279, 206, theresponseofindividualcell typesto infection.
a
bronchial
epithelialcell
transcriptional
responses
of
genome-wide
208,R&D Systems)and thenblockedwith1% BSA in PBS. One
B.pertussis
strain
witha wild-type
hourlater,10 ng of a biotinylatedpolyclonalAb (BAF 279, 206, line,BEAS-2B (8), afterinfection
had
shown
more
robust
h.
Preliminary
analyses
(BP536)
for
3
208, R&D Systems)was added for1 h. Afterwashing,bound Ab
responsesafter3 h thanafter1 h (data not shown).Steady-state
was detected by using a streptavidin-horseradish
peroxidase
6,800 humangenes was
transcript
abundancefor approximately
conjugate and tetramethylbenzadine
substrate. Cytoplasmic
ofthedata was
Reproducibility
analyzedin duplicateexperiments.
histone-associatedDNA fragments
were quantitatedas a meaoflabeledcDNA/cRNA
examinedbyusingduplicatepreparations
sureof apoptosisbyusingthe Cell Death DetectionELISA Plus
fromRNA isolatedfromeach of two replicateinfectionexperikitper manufacturer
recommendations(Roche Diagnostics).
ments.These analysesrevealed19.5% and 26.9% variationinmean
valuesforallprobesetsinthefourcomparisons.
averagedifference
Chemotaxis.
Whole humanblood was mixed 1:1 with The completedata setsforthese(Table 2) and otherexperiments
Neutrophil
dextranin PBS for45 minat 25?C.The top layerwas overlaidon
(Tables 3-8) are availableat http://relman.stanford.edu.
Ficoll-Paque (AmershamPharmacia)and centrifuged
at 450 x g
Table 1 categorizesthe named BEAS-2B genes thatexhibited
for45 min,thengranulocytes
were harvested.RBCs were lysed greaterthana 3-foldchangein steady-state
transcript
abundance
in hypotonicsaline. Neutrophilpuritywas >95%. One hundred after3 h ofinfection.
These resultsare noteworthy
forthemodest
thousandneutrophils
wereplaced on a 3-,tmfilter(Neuroprobe, numberofgenesthatrespondedtoB. pertussis
exposure,unlikethe
Cabin John,MD) separatingthem from 29 ,tl of BEAS-2B
responsesobservedat latertimepointsduringhumancytomegasupernatantin a 96-well microchamber.In some wells, anti- lovirus (10) and HIV-1 infections(J. Corbeil, D. Genini, D.
humanIL-8 Ab was added at 10 ,ug/mlforthe durationof the Sheeter,S. Rought,L. Leoni,P. Du, M. Ferguson,D. R. Masys,J.B.
experiment(MAB208, R&D Systems).After1 h at 37?C, only Welsh,J.L. Fink,etal., personalcommunication).
Of the33 genes
cells thathad passed throughthe filterwere quantifiedbyusing whose expressionlevels increasedin abundanceby greaterthan
the CyQuant Cell ProliferationKit (Molecular Probes).
themostwell-represented
3-foldon B. pertussis
category
infection,
cytokines.None of
(8) was a group encodingproinflammatory
MucinTranscription
and Binding.
HM3 cells (1.5-3 x 106) carrying thesehad been previously
but
infection,
implicatedin B. perttussis
either a MUC2 or MUC5AC promoterfusion to a luciferase theirknown chemoattractant
activitiesare consistentwith the
reportergene were infectedwithB. pertussisin DMEM without cellularinfiltrate
Our data also revealedincreased
seeninpertussis.
IL-113transcription.
IL-1 is knownto increasegrowth-regulated
FCS in triplicate.After2, 4, and 6 h, the cells were lysedfor30
minwith100 ,ulReporterLysisBuffer(LuciferaseAssaySystem, oncogene (GRO) mRNA and has been shownto play a role in
Belcheret al.
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TCT-mediatedrespiratory
epithelialcell toxicity(11, 12). Other
up-regulatedgene products,such as IKB, are involvedin NFKB
signalingand mayregulatethesecytokines(13).
The data inTable 1 revealregulation
ofseveralapoptosis-related
genes.TNFAIP3 and API2 are antiapoptotic
factorswhosegenes
are transcriptionally
up-regulatedby infection(14, 15). Furthermore,transcription
ofBTF3, a transcription
factorassociatedwith
apoptosis,is decreased(16). Giventhatmonocytesand neutrophils
havebeen describedtoundergoapoptosisinresponsetoB. pertussis
infection(17), we lookedforevidenceof apoptosisin B. pertussisinfectedBEAS-2B cells by usingan ELISA assayformono-and
oligonucleosomesat the 3-h time point used in the microarray
experiments.
Representative
data fromduplicateexperiments
revealed no evidenceof apoptosis [absorbanceof 0.028 ? 0.005
(mean ? 95% confidenceinterval)for the infectedcells and
0.029 ? 0.005 fortheuninfected
cells (P = 0.85)].
The 65 genes whose expressionlevels decreased by greater
than3-foldincludedthoseencoding10 transcription
factorsand
6 cellularadhesionmolecules.The overalltranscriptional
profile
of these infectedcells suggesteda pictureof relativelyrapid
activationand defensivehost responses.
The ADP-Ribosyltransferase
Activityof PT Is Responsiblefor Specific

Transcriptional
Responses.
To definetheroleofPT ADP-ribosylase
at thetranscriptional
activity
level,we comparedtheresponsesof
BEAS-2B cells to two pairs of stimuli:(i) wild-typePT vs. a
catalytically
inactivebutproperly
foldedPT holotoxin(9K/129G),
and (ii) wild-typeB. pertussisvs. an isogenicderivativethatexpressesPT-9K/129G.Data setsare availableas Tables 3 and 4 at
Table 5 listsgeneswhose expression
http://relman.stanford.edu;
changedmorethan3-foldwhencomparingtheeffectsofboththe
purifiedinactivetoxinwithwild-typetoxinand the toxin-mutant
strainwithits isogenicparentstrain.Thus, thesehost cell genes
representthose forwhichpertussistoxinenzymaticactivitywas
both necessaryand sufficient
to effecta change in transcript
abundance.Severalof thesegenes are G-proteinor cAMP regulated,such as those encodingmatrixmetalloproteinase
1, 13Bicrystallin,basic fibroblastgrowthfactor,and the Na+/Cl-dependentserotonintransporter.
othergenessuchas
Surprisingly,
theserum/glucocorticoid-regulated
kinase,whoseexpressionlevel
decreased,and guanylatecyclase 1, whose expressionlevel increased,showedresponsesindirections
to thosesuggested
contrary
The majorityof the PT-responsegenesrevealed
by theliterature.
in these experimentshad not been previouslyassociatedwith
G-protein activity.Thirty-eight
genes with discordant3-fold
an effectof PT activity
changes,suggesting
thatdependson other
bacterial factors,are highlighted(Table 6) at http://relman.
stanford.edu.
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Fig.1. (a-c) Changesinsecretedchemokine
for24 h. Representative
data fromduplicate
epithelialcelllineto B.pertussis
areshown.Assayswereperformed
forIL-8(a), MCP-1(b),and IL-6
experiments
(c).(d) Migration
ofneutrophils
inresponsetothesupernatants
ofB.pertussisinfectedepithelialcells.In duplicateexperiments,
neutrophils
migratedtowardthesupernatant
withorwithout10 jig/mlanti-IL-8
Ab.Migration
index
is the ratioof cellsthat migratedto a supernatantin comparisonto the
uninfected
supernatant.
Errorbarsrepresent
the95% confidence
interval
of
the meanofthreewells.

migrationassay, in which cells are separated from BEAS-2B
supernatants
bya porousmembrane.As shownin Fig. Id, 2.9-fold
moreneutrophils
wereattracted
to thesupernatant
ofinfected
cells
thanto thatof uninfected
cells.Furthermore,
cell migration
could
be partiallyinhibited(34% withthe infectedcell supernatant)by
usingan anti-IL-8mAb, suggesting
thatIL-8 contributes
to this
and indicating
chemoattractant
activity
a roleforotherchemokines
as well. AlthoughpreviousreportssuggestthatPT is capable of
inhibiting
neutrophil
chemotaxisin vitro(21), chemoattraction
was
the dominanteffectin thisexperimental
system.
Antiinflammatory
Drugs Suppress the EpithelialCell Responses to B.

The data presentedabove and in Table 1 reveal uppertussis.
regulationof geneswhoseproductsplaya role in NFKB activation
as wellas genesknownto be regulatedbyNFKB. We hypothesized
that pretreatment
of the epithelialcells with antiinflammatory
drugs that interferewith NFKB activationcould help confirm
mechanismsby whichB. pertuissis
stimulatesa proinflammatory
cellularresponse.Dexamethasonewas chosenbecause glucocorticoids have been suggestedas a therapyforpertussis,despitethe
The Chemokine Response of B. pertussis-InfectedEpithelial Cells
paucityofsupportive
data (22). Glucocorticoids
mayinhibitNFKB
Overcomes
theAntichemotactic
of PT.The knownactivities activity
Activity
IKB synthesis
or through
byaugmenting
associationoftheir
of PT and otherB. pertussisvirulencefactorssuch as adenylate bound receptorsto NFKB (23). Sodium salicylateinhibitsNFKB
cyclasetoxinsuggestthattheymightbe capable of blockingthe activationof genesbypreventing
of IKB (24).
phosphorylation
chemotacticresponsepredictedby our data (18). We firstdocuThe transcriptional
responsesof BEAS-2B cellspretreated
with
mentedthe predictedproteinexpressionresponsesforseveralof
eithersodiumsalicylateor dexamethasoneand thenexposedto B.
the cytokinegenes thatwere inducedin BEAS-2B cells. Fig. la
BP536 differed
pertussis
fromuntreatedcells (Tables 7
profoundly
showsan increasein secretedIL-8 from35 ? 0.8 (mean ? 95%
and
8,
Pretreatment
eliminatedthe
http://relman.stanford.edu).
confidenceinterval)to 678 ? 78 ng/ml(P = 0.0006) and MCP-1
inductionof GRO-2, GRO-1, IL-8, IL-6, ILfrom580 ? 29 to 3367 ? 349 ng/ml(P = 0.004) (Fig. lb) whenthe infection-associated
supernatantsof BEAS-2B cells were harvestedafter24 h of 13, MCP-1, MIP-la, GRO-3, CIITA, HLA-DQ, API2/IAP, and
othergenesthatwereinducedin untreatedcells.However,differexposure to B. pertussisor mock infection.Inductionof IL-6
secretionwas also confirmed,
withnone detectablein uninfected ences were also noted in the effectsof these two inhibitors.
inwhereas116 ? 2 ng/mlwas detectedin supernatants Dexamethasonefailedto block a 2.9-foldinfection-associated
supernatants,
ductionoftheantiapoptotic
moleculeTNFAIP3, whereassalicylate
frominfectedcells (P < 2.5 x 10-7) (Fig. lc).
dexamethasone
led to a
Furthermore,
pretreatment
IL-8 and the GRO familyof chemokinesare strongneutrophil was inhibitory.
4.8-foldinfection-associated
increasein expressionofiNOS, which
chemoattractants
thathave notbeen previously
associatedwithB.
cellsor in theabsenceofdrug
pertussis infection(19, 20). We examinedthe chemoattractant was notseen in salicylate-pretreated
activityof the BEAS-2B cell supernatants
by usinga neutrophil pretreatment.
Transcription
of IL-1,whichhas been implicatedin
13850 | www.pnas.org
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the inductionof iNOS activity(12), was not detectedin dexamethasone-treated
cells.
B. pertussis Binds Mucin and Induces Its Expression by Bronchial

Epithelial
Cells.The regulatedexpressionof mucinin the respiratorytractis one innatehostdefensethatrespiratory
pathogens
mustovercome.Given previouslypublishedevidence of mucin
noxiousstimuli,
we examined
gene responsesto otherrespiratory
our microarray
expressiondata forresponsesbythe mucingene
family.MUC2, whichencodes a respiratorytractmucinglycoprotein,was expressed at 1.5-fold increased levels in cells
whereasno responsewas notedforMUC3
exposedtoB. pertussis,
(encodes intestinalmucin) and MUC6 (encodes gastricmucin).
These data promptedfurther
investigation
byusinga systemthat
is more sensitiveto smallchangesin mucingene transcriptional
activity.MUC2 and MUC5AC [also shownto be transcribedin
respiratory
epithelium(25)] werestudiedbyusingepithelialcells
thatharbora stable transfected
copyof theMUC2 or MUC5AC
promoterfused to a luciferasereportergene. Transcriptionof
MUC2 and MUC5AC increasedduringthe experimentin both a
dose- and time-dependentmanner(Fig. 2 a and b). At 6 h, the
highestbacterialdose gave 32-fold(P = 0.002) and 17-fold(P =
0.01) increases in MUC2- and MUC5AC-luciferaseactivities,
respectively.To our knowledge,there have been no previous
descriptionsof mucingene responsesto B. pertussisinfection.
Giventhe abilityofB. pertussisto inducemucingene transcription,we hypothesizedthat the bacteriummightbe capable of
adheredto microtiter
bindingmucin.Fig. 2c showsthatB. pertussis
platesat 4-foldhigherlevelswhenthewellswerecoatedwithbovine
salivarymucinand thentreatedwitha nonspecific
blockingagent
(nonfatdrymilk)thantheydid to wellstreatedwiththeblocking
agentalone (P < 6 x 10-12). A relatedspecies,Bordetellabronchisepticahas been shownto bind to swine nasal mucosa sialyl
mucin(26). Evaluationofseveralglycoglycoconjugates,
including
conjugatesrevealedthata sialic acid-containing
gangliosidemixturewas able to inhibitB. pertussis
bindingto mucinby32% (P <
acid blockedbindingbetterthanN0.005). N-acetyl-neuraminic
but neitherproduceda significant
decrease
acetyl-D-glucosamine,
(22% and 12%,P valuesof0.07 and 0.32,respectively).
These data
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Fig.2. (a andb) Induction
genesbyB.pertussis
a mucin-luciferase
an epithelial
celllinecarrying
duplicateexperiments,
reporter
wasexposedtovarying
numbers
ofB.pertussisfor
genefusion
increasing
periods
oftime.Representative
datafromoneexperiment
inwhichthefusioncontained
thepromoter
fromMUC2 (a) orthepromoter
fromMUC5AC (b) areshown.(c)
of B. pertussis
to mucin-coated
Binding
plates.One setof data fromtriplicate
thatdemonstrates
and
to mucin-coated
experiments
bindingof B. pertussis
blockedwellsvs.thosecoatedwithblocking
fluoresagentalone.Background
cenceofthemucinand nonfatmilkare demonstrated
bythethirdand fourth
bars.Error
barsrepresent
the95% confidence
interval.
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to mucinis mediatedbysialic
suggestedthatbindingofB. pertussis
compounds.
acid-containing
Discussion

DNA microarraysto surveygenomeThe use of high-density
responses in host cells afterexposure to
wide transcriptional
microbialpathogensis a powerfulapproach to understanding
(10, 27, 28) (J.Corbeil,D. Genini,D.
host-pathogeninteractions
Sheeter,S. Rought,L. Leoni, P. Du, M. Ferguson,D. R. Masys,
J.B. Welsh,J.L. Fink,etal., personalcommunication).Our data
providean overviewof the interactionbetweenB. pertussisand
and
respiratory
epithelialcells at the level of gene transcription
suggest a number of testable hypotheses.Our studies have
state in B. pertussisrevealed a dominant proinflammatory
exposed bronchial epithelial cells and the inductionof host
defensesthatmightbe coopted or subvertedbythispathogen.In
addition,we have documentedresponsesby a numberof genes
thatwere notpreviouslyknownto be associatedwithB. pertussis
or itsvirulencefactors.
designand data
As withany model system,our experimental
Transformed
cell linesmayrespondin a manner
have limitations.
fromthatof primarycellsbyvirtueof alteredcontrolson
distinct
we are limitedby data
Furthermore,
growthand differentiation.
ofinfection.
fromonlya singletimepointand a singlemultiplicity
Our systemis also limitedby the presenceof onlyone cell type,
whereasin an infectedhost,the responsesof bronchialepithelial
cells would be modifiedby the presenceof otherimmuneand
nonimmunecells and a wide varietyof soluble factors.These
limitationswere accepted to create an easily controlled,easily
between
manipulated,and reproduciblemodel of the interaction
B. pertussisand itsprimarytargetcell.
B. pertussis-InfectedBronchial Epithelial Cells Exhibit a TranscripResponse. Eight of the
tional ProfileDominatedbya Proinflammatory
thirty-three
genes thatmet our inductioncriteriaon B. pertulssis

cytokines.This host response
infectionencode proinflammatory
infection.
forB. pertussis
profilehas notbeen describedpreviously
Althoughthe chemokinesIL-8, GRO-1, GRO-2, and GRO-3 are
MCP-1 and SCYA3 promote
chemoattractants,
strongneutrophil
(19, 20, 29). IL-8, GRO-1, and SCYA3 have
monocyteinfiltration
chemoattractant
properties
also been shownto exertlymphocyte
seen in autopsy
(30, 31). These resultshelpto explaintheinfiltrate
andinanimalmodelsofthedisease
studiesofhumanswithpertussis
IL-8, MCP-1, and GRO-1 are known to
(1, 2). Furthermore,
promoteexpressionof CD11b/CD18 (CR3) on the surfaceof
and monocytes(32, 33). This leukocyteintegrinis a
neutrophils
filamentous
hemagreceptorforthemajoradhesinofB. pertussis,
glutinin(34). However,thebindingofB. pertussisto leukocytesis
detrimental
to thispathogen:theorganisminhibits
notnecessarily
its
oxidativeburstand intracellular
killingand insteadup-regulates
T cell
own bindingto thesecells and inhibitsantigen-dependent
has adaptedto the
proliferation
(34, 35). This suggestsB. pertussis
inflammatory
responsethatitelicitsfrombronchialepithelialcells.
The NFKBPathway Is Activated in B. pertussis-InfectedCells Without

EvidenceofApoptosis.
Our studyofhumanbronchialepithelialcells
pathwaysare
indicatesthatactivationof NFKB and downstream
as has been implicated
dominantfeaturesofB. pertussisinfection,
and sodium
in otherinfections
(27, 36). The use ofdexamethasone
because both inhibitNFKB activasalicylatesupportthisfinding,
tion,and theyabolishedtheresponsesof geneswhichwe propose
is
were inducedbyNFKB. TRIP, whichinhibitsNFKB activation,
on infection,therebyallowingNFKB activation
down-regulated
thetranscriptional
changesinTNFAIP3, API2,
(37). Furthermore,
and BTF are suggestiveof antiapoptoticsignaling,despite the
apoptosisin monocytes
previousfindingsof B. pertussis-induced
marker
and neutrophils
(17). In addition,our use of a phenotypic
for apoptosis,the appearance of mono- and oligonucleosomes,
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revealedno evidenceof apoptosisin the infectedcells after3 h.
transcription
ofiNOS (14). Thus,our data indicatethedominance
Thus,B. pertussis
mayhaveevolvedspecificmechanismsforkilling of otherpositiveregulatory
factorson iNOS expression.Fromthe
perspective
ofdiseasemanagement,
thesedata maysuggestcaution
inflammatory
cells while sparingthe nonciliatedepitheliumon
in the use of corticosteroids
forpatientswithwhoopingcough.
whichit survives.
These agentsare predictedto worsenTCT-mediatedinductionof
PT-Responsive
GenesPresentCluesto thePathogenesis
of Pertussis. iNOS and subsequentadverse effectson neighboringciliated
inactivetoxinand a strainbearingthis epithelialcells.
Our use of a catalytically
mutanttoxin allowed us to investigatethe role of the ADPribosyltransferase
activityofPT withouttheconfoundingeffects B. pertussisSubvertsthe MucociliaryEscalator. Although mucus is
of otherPT-associated activities.In BEAS-2B cells, two collaoften considered a host defense; in some diseases, such as
genases, fibroblast activation protein and matrix metal- asthma, bronchitis,and cysticfibrosis,it contributesto the
loproteinaseI (MMP-1) were transcriptionally
down-regulated pathology.Our data show that B. pertussis,like many other
by the enzymaticactivityof PT. MMP-1 transcriptionis in- infectiousagents or irritants,is capable of inducing mucin
With an intactmucociliaryescalator,mucinprocreased by otherinfections(38) and by basic fibroblastgrowth transcription.
factor(39), whose transcription
was increasedby PT catalytic vides an importanthousekeepingfunction.However,lipopolysaccharide,in combinationwithTCT of B. pertussis,paralyzes
activity.
Down-regulationofMMP-1 expressionappearsto be an
activeprocessand one thatis unexpected.An examinationofthe ciliatedepithelialcells and causes theirdeath and extrusion(6),
responses elicited by this toxin on other cell typeswill likely leading to a buildup of respiratorysecretions.As described
above, PT-induced alterationsin VIP and serotoninsignaling
reveal manyotherG-protein-linked
genes.
Transcriptionalanalysissuggeststhatthe quantityand quality could lead to thickerand even more tenaciousmucus.We have
thatB. pertussisis able to bindto mucin,suggesting
of respiratorysecretionsare altered by the ADP-ribosylase demonstrated
thatthe pathogenmaybe manipulatinghost defensesto create
activityof PT. The product of the down-regulatedVIP gene
foritself.
increases secretionof Cl- in epithelialcells (40). In the lung, a favorablemicroenvironment
serotoninmediatesairwayreactivityand causes fluidtransport
Conclusion.
Transcriptional
analysisof infectedepithelialcells has
across the epitheliumintothe tracheallumen(41). Serotoninis
cleared by a transporter,
whose gene, SLC6A4, is up-regulated helpedto revealthemechanismsbywhichthehostrespondsto B.
byPT. Throughtheseregulatoryevents,B. pertussismaymodify pertussisand some of the mechanismsby whichthis pathogen
attemptsto subverthost defenses.Our data help to integrate
the physicalpropertiesof the respiratorytractmucus. This is
information
about the pathologyof pertussis,pathoborne out by descriptionsof thicktenaciousmucus at autopsy. preexisting
and host cell phenogen-hostand receptor-ligand
interactions,
A morecomprehensive
examiof NFKBActivation
Inhibition
byAntiinflammatory
AgentsHas Ther- types,withvirulencemechanisms.
responsesofpathogensand theirhostswill
apeuticImplications.
Previousstudieshave proposedthatcortico- nationoftranscriptional
used byboth.
steroidsmay have some benefitin the treatmentof pertussis help defineconservedand specificstrategies
theireffecton transcription
ofproinflammatory
through
effectors
andis
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